cotinine-n-oxide has been researched along with Diabetes Mellitus, Type 2 in 1 studies
*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Din Selim, MM; Graaff, R; Lutgers, HL; Mook-Kanamori, DO; Mook-Kanamori, MJ; Slagter, SN; Suhre, K; van der Klauw, MM; van Vliet-Ostaptchouk, JV; van Waateringe, RP; Wolffenbuttel, BHR | 1 |
1 other study(ies) available for cotinine-n-oxide and Diabetes Mellitus, Type 2
Article | Year |
---|---|
The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation.
Topics: Adult; Aged; Biomarkers; Cohort Studies; Cotinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Humans; Male; Middle Aged; Saliva; Skin; Smoking; Smoking Cessation; Spectrometry, Fluorescence; Time Factors; Tobacco Smoke Pollution | 2017 |